Pioneering biotechnology solutions for the future of healthcare.
Our Ecosystem
Cellular platforms designed to connect discovery-stage biology with translational experimental evidence.
Molecular readouts and biomarker strategies that transform complex biology into actionable insight.
Functional testing of bioactives, biomaterials and formulations across biological performance endpoints.
Recombinant and bioprocess workflows shaped for scalable, industry-ready biotechnology development.
Preclinical model systems designed to evaluate biological efficacy, safety and disease relevance.
Scientific and strategic support for clinical translation, grants, theses and publication-ready outputs.
Cellular platforms designed to connect discovery-stage biology with translational experimental evidence.
Molecular readouts and biomarker strategies that transform complex biology into actionable insight.
Functional testing of bioactives, biomaterials and formulations across biological performance endpoints.
Recombinant and bioprocess workflows shaped for scalable, industry-ready biotechnology development.
Preclinical model systems designed to evaluate biological efficacy, safety and disease relevance.
Scientific and strategic support for clinical translation, grants, theses and publication-ready outputs.
Our Ecosystem
An integrated translational platform connecting cellular models, molecular insight, bioactive testing and industry-ready development.
Cellular platforms designed to connect discovery-stage biology with translational experimental evidence.
Selected Project Portfolio
24 programmes
Selected academic, clinical, translational and product-development programmes spanning precision oncology, precision psychiatry, biologics development, tissue engineering, neuroscience, molecular diagnostics, formulation science and sustainable biomanufacturing.
Filters
We partner with innovators in biotechnology, pharmaceuticals and cosmetics to turn ambitious ideas into validated solutions.
Insights & News
The talks, partnerships and science behind our work.
On stage and in the field — international conferences, congresses and invited lectures.
Best Abstracts Session
Our work on NMDAR1A- and IL-10-centered neuroimmune targeting in chronic pancreatitis has been selected for oral presentation in the Best Abstracts · Chronic Pancreatitis session at the EPC / IAP Joint Meeting 2026 in Istanbul.
Read full page→Chronic Pancreatitis · Pain Biology
An oral lecture on targeting NMDA Receptor 1A to ameliorate pain in chronic pancreatitis, marking a major milestone after three consecutive years of EPC visibility.
Read full page→Neuroimmune Targeting · Monoclonal Antibody
A hybridoma-derived CX3CR1-targeting monoclonal antibody strategy was presented as an oral presentation, highlighting neuroimmune pain modulation in pancreatic disease.
Read full page→Neuroimmune Targeting · Monoclonal Antibody
A hybridoma-derived CX3CR1-targeting monoclonal antibody strategy was presented as an oral presentation at the European Federation of Immunological Societies, highlighting neuroimmune pain modulation in pancreatic disease.
Read full page→Flash Talk Under Review
Our study on the transition from chronic pancreatitis to pancreatic cancer was accepted for poster presentation with travel grant support, focusing on TG2 fibrosis, senescence and neuroimmune pain.
Read full page→Nerve–Tumour–Immune Crosstalk
Our poster explored how NMDA receptor signalling may shape the dialogue between nerves, tumour cells and immune cells in pancreatic cancer and chronic pancreatitis.
Read full page→European Association for Cancer Research
Imperion co-founders Deniz Baybağ and Nedim Can Çevik were selected as EACR Ambassadors, supporting the visibility of cancer research opportunities and scientific networks across Europe.
Read full page→Featured Alongside Leading Industry Names
Imperion Biotechnology joined geneXplore as a featured participant alongside major names including AstraZeneca, Novartis, Atabay Biotechnology and Nobel İlaç.
Read full page→Students · Researchers · Translational Biotechnology
Imperion co-founders were invited to share the company’s story, scientific direction and translational biotechnology vision with students and young researchers.
Read full page→Let's Work Together
Partner with Imperion Biotech to bring your most ambitious projects to life. Let's shape the future of biotechnology together.